Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk

Hankinson, 2004, Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle and hormones, Breast Cancer Res., 6, 213, 10.1186/bcr921

van den Brandt, 2000, Pooled analysis of prospective cohort studies on height, weight and breast cancer risk, Am. J. Epidemiol., 152, 514, 10.1093/aje/152.6.514

Cuzick, 2003, Overview of the main outcomes in breast-cancer prevention trials, Lancet, 361, 296, 10.1016/S0140-6736(03)12342-2

Baum, 2002, Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial, Lancet, 359, 2131, 10.1016/S0140-6736(02)09088-8

Henderson, 2000, Hormonal carcinogenesis, Carcinogenesis, 21, 427, 10.1093/carcin/21.3.427

Liao, 2002, Roles of androgens in the development, growth and carcinogenesis of the mammary gland, J. Steroid Biochem. Mol. Biol., 80, 175, 10.1016/S0960-0760(01)00185-6

Lanari, 2002, Progesterone receptors: animal models and cell signaling in breast cancer. Diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancer, Breast Cancer Res., 4, 240, 10.1186/bcr539

Campagnoli, 2005, Progestins and progesterone in hormone replacement therapy and the risk of breast cancer, J. Steroid Biochem. Mol. Biol., 96 B, 95, 10.1016/j.jsbmb.2005.02.014

Toniolo, 1994, Reliability of measurements of total, protein-bound and unbound estradiol in serum, Cancer Epidemiol. Biomarkers Prev., 3, 47

Hankinson, 1995, Reproducibility of plasma hormone levels in postmenopausal women over a 2–3-year period, Cancer Epidemiol. Biomarkers Prev., 4, 649

Micheli, 1991, Repeated serum and urinary androgen measurements in premenopausal and postmenopausal women, J. Clin. Epidemiol., 44, 1055, 10.1016/0895-4356(91)90007-V

Muti, 1996, Reliability of serum hormones in premenopausal and postmenopausal women over a 1-year period, Cancer Epidemiol. Biomarkers Prev., 5, 917

Missmer, 2006, Reproductibility of plasma hormone and growth factor levels among premenopausal women over a 2–3-year period, Cancer Epidemiol. Biomarkers Prev., 15, 972, 10.1158/1055-9965.EPI-05-0848

Michaud, 1999, Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a 1-year period, Cancer Epidemiol. Biomarkers Prev., 8, 1059

Willett, 1998

van Landeghem, 1985, Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue, Cancer Res., 45, 2900

Thijssen, 1987, Estrogens in tissues: uptake from the peripheral circulation or local production, Steroids, 50, 297, 10.1016/0039-128X(83)90079-X

Vermeulen, 1986, 17-β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women, Eur. J. Cancer Clin. Oncol., 22, 515, 10.1016/0277-5379(86)90121-5

Recchione, 1995, Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues, J. Steroid Biochem. Mol. Biol., 52, 541, 10.1016/0960-0760(95)00017-T

Mady, 2000, Sex steroid hormones in serum and tissue of benign and malignant breast tumor patients, Dis. Markers, 16, 151, 10.1155/2000/305940

Key, 2002, Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies, J. Natl. Cancer Inst., 94, 606, 10.1093/jnci/94.8.606

Manjer, 2003, Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden), Cancer Causes Control, 14, 599, 10.1023/A:1025671317220

Key, 1996, A prospective study of urinary oestrogen excretion and breast cancer risk, Br. J. Cancer, 73, 1615, 10.1038/bjc.1996.304

Onland-Moret, 2003, Urinary endogenous sex hormone levels and the risk of postmenopausal breast cancer, Br. J. Cancer, 88, 1394, 10.1038/sj.bjc.6600890

Kaaks, 2005, Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition, Endocr. Relat. Cancer, 12, 1071, 10.1677/erc.1.01038

Zeleniuch-Jacquotte, 2004, Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study, Br. J. Cancer, 90, 153, 10.1038/sj.bjc.6601517

Missmer, 2004, Endogenous estrogen, androgen and progesterone concentrations and breast cancer risk among postmenopausal women, J. Natl. Cancer Inst., 96, 1856, 10.1093/jnci/djh336

Beattie, 2006, Endogenous sex hormones, risk of breast cancer, and response to tamoxifen: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1), JNCI, 10.1093/jnci/djj011

Eliassen, 2006, Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women, J. Natl. Cancer Inst., 98, 1406, 10.1093/jnci/djj376

Tworoger, 2005, Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones, J. Natl. Cancer Inst., 97, 595, 10.1093/jnci/dji099

Fisher, 1998, Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study, J. Natl. Cancer Inst., 90, 1371, 10.1093/jnci/90.18.1371

Colditz, 2000, Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses’ Health Study, Am. J. Epidemiol., 152, 950, 10.1093/aje/152.10.950

Tyrer, 2004, A breast cancer prediction model incorporating familial and personal risk factors, Stat. Med., 23, 1111, 10.1002/sim.1668

Freedman, 2005, Cancer risk prediction models: a workshop on development, evaluation and application, J. Natl. Cancer Inst., 97, 715, 10.1093/jnci/dji128

Cummings, 2002, Serum estradiol level and risk of breast cancer during treatment with raloxifene, J. Am. Med. Assoc., 287, 216, 10.1001/jama.287.2.216

Wysowski, 1987, Sex hormone levels in serum in relation to the development of breast cancer, Am. J. Epidemiol., 125, 791, 10.1093/oxfordjournals.aje.a114596

Helzlsouer, 1994, A prospective study of endogenous hormones and breast cancer, Cancer Detect. Prev., 18, 79

Rosenberg, 1994, Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle, Am. J. Epidemiol., 140, 518, 10.1093/oxfordjournals.aje.a117278

Thomas, 1997, A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey, Br. J. Cancer, 75, 1075, 10.1038/bjc.1997.183

Kabuto, 2000, A prospective study of estradiol and breast cancer in Japanese women, Cancer Epidemiol. Biomarkers Prev., 9, 575

Kaaks, 2005, Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC), J. Natl. Cancer Inst., 97, 755, 10.1093/jnci/dji132

Micheli, 2004, Endogenous sex hormones and subsequent breast cancer in premenopausal women, Int. J. Cancer, 112, 312, 10.1002/ijc.20403

Thomas, 1997, A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey, Br. J. Cancer, 76, 401, 10.1038/bjc.1997.398

Siiteri, 1973, Estrogen binding in the rat and human, Adv. Exp. Med. Biol., 36, 97, 10.1007/978-1-4684-3237-4_6

Siiteri, 1981, Extraglandular oestrogen formation and serum binding of oestradiol: relationship to cancer, J. Endocrinol., 89, 119P

Bulun, 1993, A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription, J. Clin. Endocrinol. Metab., 77, 1622, 10.1210/jc.77.6.1622

Ricketts, 1991, Estrogen and progesterone receptors in the normal female breast, Cancer Res., 51, 1817

Markopoulos, 1988, Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle, Br. Med. J. (Clin. Res. Ed. ), 296, 1349, 10.1136/bmj.296.6633.1349

Yue, 1998, Determinants of tissue estradiol levels and biologic responsiveness in breast tumors, Breast Cancer Res. Treat., 49, S33, 10.1023/A:1006026732129

Gompel, 2000, Hormonal regulation of apoptosis in breast cells and tissues, Steroids, 65, 593, 10.1016/S0039-128X(00)00172-0

Sabourin, 1994, P.Poitout, bcl-2 expression in normal breast tissue during the menstrual cycle, Int. J. Cancer, 59, 1, 10.1002/ijc.2910590102